01 / Vendor Profile
PINE PHARMACEUTICALS, LLC Federal Contracts and Awards
UEI TCJXKNYD6WL5 · CAGE 7JZE9
Federal contract activity attributed to this vendor identity across FY 2020–FY 2026. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2020–FY 2026.
Across FY 2020–FY 2026, FPDS records attribute $2.23M in net contract obligations to PINE PHARMACEUTICALS, LLC across 52 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
PINE PHARMACEUTICALS, LLC contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations$628.9K
FY 2026ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2020 | $97.4K | 4 | 1 | — |
| FY 2021 | $68.4K | 4 | 1 | −29.8% |
| FY 2022 | $187.0K | 6 | 1 | +173.5% |
| FY 2023 | $619.8K | 8 | 1 | +231.5% |
| FY 2024 | $180.2K | 9 | 2 | −70.9% |
| FY 2025 | $448.9K | 9 | 2 | +149.1% |
| FY 2026 | $628.9K | 12 | 2 | +40.1% |
04 / Federal Customers
Which federal agencies buy from PINE PHARMACEUTICALS, LLC?
Ranked by net obligations during FY 2020–FY 2026.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 7529 | $2.13M | 43 | 95.7% | |
| 3600 | $96.5K | 9 | 4.3% |
05 / Contracting Offices
Which contracting offices buy from PINE PHARMACEUTICALS, LLC?
Ranked by net obligations during FY 2020–FY 2026.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 75N940 | NATIONAL INSTITUTES OF HEALTH | $1.30M | 26 | 58.1% | |
| 75N980 | NATIONAL INSTITUTES OF HEALTH | $743.3K | 6 | 33.3% | |
| 36C263 | VETERANS AFFAIRS, DEPARTMENT OF | $96.5K | 9 | 4.3% | |
| 75N950 | NATIONAL INSTITUTES OF HEALTH | $57.7K | 6 | 2.6% | |
| 75N98C | NATIONAL INSTITUTES OF HEALTH | $24.7K | 1 | 1.1% | |
| 75N92E | NATIONAL INSTITUTES OF HEALTH | $12.0K | 2 | 0.5% | |
| 75N900 | NATIONAL INSTITUTES OF HEALTH | $0 | 2 | 0.0% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | $1.64M | 38 | 2 | 73.6% |
| 325199 | ALL OTHER BASIC ORGANIC CHEMICAL MANUFACTURING | $318.8K | 3 | 1 | 14.3% |
| 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | $150.1K | 8 | 1 | 6.7% |
| 339112 | SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING | $122.0K | 1 | 1 | 5.5% |
| 541380 | TESTING LABORATORIES | -$50 | 1 | 1 | 0.0% |
| 334516 | ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING | -$2.7K | 1 | 1 | -0.1% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
08 / Competition Pattern
How was PINE PHARMACEUTICALS, LLC’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for PINE PHARMACEUTICALS, LLC?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 75N94021P00105 | Aug 20, 2026 | -$466 | NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH NICHD | 325412 | 6505 |
10 / Interpreting the Profile
How should you evaluate PINE PHARMACEUTICALS, LLC as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.